top of page

Teléfono: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

​Inicio >

Lenvanamo 10mg Capsule

Lenvanamo 10mg Capsule

Manufacturer/Marketed By : SHIVNAAM TRADELINK LLP

$122.68 $49.07

Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial....

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

LENVATINIB

Active Pharmaceutical Ingredient

Lenvanamo 10mg Capsule

SKU SHIVNAAM TRADELINK LLP
Precio original

122,68 US$

Precio de oferta

49,07 US$

Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvanamo 10mg Tablet or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvanamo 10mg Tablet, as it can impair wound healing and increase the risk of bleeding.

Active Pharmaceutical Ingredient

LENVATINIB

​Usos

• Certain types of advanced thyroid cancer
• Advanced Liver cancer
• Certain types of kidney cancer
• Endometrial cancer

Beneficios

Lenvanamo 10mg Tablet blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumour cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.

Efectos secundarios

Like all medications, Lenvanamo 10mg Tablet can cause side effects, although not everyone who takes it will experience them.

Efectos secundarios más comunes

• Fatigue
• Loss of appetite
• Weight loss
• Nausea and vomiting
• Diarrhea
• Stomach pain or discomfort
• Hypertension (high blood pressure)
• Headache
• Joint pain or muscle pain
• Changes in taste

Efectos secundarios comunes

• Liver toxicity or liver failure
• Heart problems, such as heart attack
• Hemorrhage (bleeding)
• Blood clots
• Poor wound healing
• Kidney failure
• Hypothyroidism
• Skin reactions (rash or blisters)

​Cómo utilizar

Lenvanamo 10mg Tablet is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up the second dose.

Safety Advice

• Breast Feeding: Breastfeeding is not recommended while taking Lenvanamo 10mg Tablet, as it can potentially harm the nursing infant.
• Alcohol: It is recommended to avoid consuming alcohol while taking Lenvanamo 10mg Tablet, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Lenvanamo 10mg Tablet is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be a sign of liver damage or inflammation. Patients taking this medication require regular blood tests to monitor liver function.
• Lungs: Lenvanamo 10mg Tablet can cause side effects that affect the lungs, such as cough, shortness of breath, and difficulty breathing. If a person experiences any of these symptoms while taking it, they should notify their healthcare provider right away.
• Driving: Patients receiving Lenvanamo 10mg Tablet should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Lenvanamo 10mg Tablet is unsafe during pregnancy as it can cause fetal harm. It is s recommended to avoid this medication during pregnancy.

​Descargo de responsabilidad

Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.

Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.

Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.

Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.

bottom of page